Word

SMART CELLS FOR LIFE

Status

Registered

Status Code

700

Status Date

Tuesday, July 12, 2022

Serial Number

79311713

Registration Number

6784096

Registration Date

Tuesday, July 12, 2022

Mark Type

4000

Filing Date

Thursday, February 4, 2021

Published for Opposition

Tuesday, April 26, 2022

Trademark Owner History

Tigen Pharma SA - Original Registrant

Classifications

5 Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases; none of the foregoing being dietary and nutritional supplement or skin care products

1 Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals; none of the foregoing being silicon and semiconductor materials or chemical compounds in the nature of Gallium arsenide, Indium phosphide, Indium gallium arsenide, Indium gallium arsenide phosphide, for the production of enzyme substrates in the field of microelectronics and none of the foregoing being dietary and nutritional supplement or skin care products

44 Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists; none of the foregoing being dietary and nutritional supplement or skin care products

10 Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions; none of the foregoing being dietary and nutritional supplement or skin care products

42 Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services; none of the foregoing being dietary and nutritional supplement or skin care products

Trademark Events

Dec 31, 2023

New Representative At Ib Received

Nov 14, 2022

Final Decision Transaction Processed By Ib

Oct 21, 2022

Final Disposition Notice Sent To Ib

Oct 21, 2022

Final Disposition Processed

Oct 12, 2022

Final Disposition Notice Created, To Be Sent To Ib

Jul 12, 2022

Notice Of Registration Confirmation Emailed

Jul 12, 2022

Registered-Principal Register

May 3, 2022

Notification Processed By Ib

Apr 26, 2022

Official Gazette Publication Confirmation E-Mailed

Apr 26, 2022

Published For Opposition

Apr 13, 2022

Notification Of Possible Opposition Sent To Ib

Apr 13, 2022

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 6, 2022

Notification Of Notice Of Publication E-Mailed

Mar 24, 2022

Approved For Pub - Principal Register

Mar 24, 2022

Examiner's Amendment Entered

Mar 24, 2022

Notification Of Examiners Amendment E-Mailed

Mar 24, 2022

Examiners Amendment E-Mailed

Mar 24, 2022

Examiners Amendment -Written

Feb 15, 2022

Teas/Email Correspondence Entered

Feb 14, 2022

Correspondence Received In Law Office

Feb 14, 2022

Teas Response To Office Action Received

Oct 4, 2021

Refusal Processed By Ib

Sep 14, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Sep 14, 2021

Refusal Processed By Mpu

Sep 14, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Sep 13, 2021

Non-Final Action Written

Aug 27, 2021

Assigned To Examiner

Aug 27, 2021

New Representative At Ib Received

Jun 5, 2021

Application Filing Receipt Mailed

Jun 1, 2021

New Application Office Supplied Data Entered

May 27, 2021

Sn Assigned For Sect 66a Appl From Ib